Tender detail

Conclusion of non-exclusive rebate agreements for etanercept and epoetin alfa/zeta

Summary

GWQ ServicePlus AG is procuring non-exclusive rebate agreements for the active substances etanercept (ATC L04AB01) and epoetin alfa/zeta (ATC B03XA01), on behalf of the health insurers in the ARGE-OH-BioTech group. The agreements are intended to start on 1 January 2027.

Reference number
0d1492ae-2a7d-4be5-8c80-c93a6709bcb9
Buyer
GWQ ServicePlus AG
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-19
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.